Acceptance of COVID-19 vaccine among persons experiencing homelessness in the City of Rome, Italy.
Adult
Aged
Attitude to Health
COVID-19
/ prevention & control
COVID-19 Vaccines
/ therapeutic use
Female
Hepatitis A
/ prevention & control
Hepatitis A Vaccines
/ therapeutic use
Hepatitis B
/ prevention & control
Hepatitis B Vaccines
/ therapeutic use
Ill-Housed Persons
Humans
Influenza Vaccines
/ therapeutic use
Influenza, Human
/ prevention & control
Male
Middle Aged
Patient Acceptance of Health Care
Rome
SARS-CoV-2
Tuberculosis
/ prevention & control
Tuberculosis Vaccines
/ therapeutic use
Vaccination Coverage
/ statistics & numerical data
Young Adult
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
entrez:
20
4
2021
pubmed:
21
4
2021
medline:
1
5
2021
Statut:
ppublish
Résumé
Vulnerable populations are being more severely impacted by the ongoing pandemic, and the recent release of vaccines for Coronavirus Disease 19 (COVID-19) may offer them protection. The aim of this study was to investigate the willingness of homeless persons to be vaccinated against COVID-19; secondary aims were to analyze the immunization coverage for other conditions. The acceptance of COVID-19 vaccine and immunization coverage for other conditions were investigated through a form in 112 persons experiencing homelessness referring to the primary care medical services of the Eleemosynaria Apostolica, Holy See. Most subjects, with a male preponderance, were willing to be vaccinated against COVID-19 (64.3%), 3.6% were unsure and 32.1% preferred not to be vaccinated. When answering questions on the immunization coverage for tuberculosis and hepatitis A and B, most subjects reported not to be vaccinated (48.2%, 56.2% and 55.3%, respectively) or did not know (33%, 28.6% and 27.7%). A significant portion of our sample declared to be willing to be vaccinated against COVID-19. It would be auspicious that the recent statements from several countries on the importance to extend COVID-19 vaccination to fragile populations be followed by the distribution of the vaccine to these populations.
Identifiants
pubmed: 33877682
doi: 10.26355/eurrev_202104_25568
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Hepatitis A Vaccines
0
Hepatitis B Vaccines
0
Influenza Vaccines
0
Tuberculosis Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM